New Zealand markets close in 48 minutes

Jiangsu Chinagreen Biological Technology Co.,Ltd. (300970.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
11.92+0.17 (+1.45%)
As of 11:57AM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 1.39B
Enterprise value 1.25B
Trailing P/E 28.98
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.39
Price/book (mrq)0.91
Enterprise value/revenue 1.36
Enterprise value/EBITDA 23.44

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-48.65%
S&P500 52-week change 323.12%
52-week high 324.67
52-week low 39.27
50-day moving average 313.28
200-day moving average 315.56

Share statistics

Avg vol (3-month) 34.98M
Avg vol (10-day) 31.75M
Shares outstanding 5117.89M
Implied shares outstanding 6118.8M
Float 860.56M
% held by insiders 152.40%
% held by institutions 14.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.2
Forward annual dividend yield 41.70%
Trailing annual dividend rate 30.20
Trailing annual dividend yield 31.70%
5-year average dividend yield 4N/A
Payout ratio 426.82%
Dividend date 3N/A
Ex-dividend date 404 Jun 2024
Last split factor 22:1
Last split date 309 Jul 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -10.65%
Operating margin (ttm)0.49%

Management effectiveness

Return on assets (ttm)-3.00%
Return on equity (ttm)-6.33%

Income statement

Revenue (ttm)920.56M
Revenue per share (ttm)8.43
Quarterly revenue growth (yoy)-22.80%
Gross profit (ttm)N/A
EBITDA 21.58M
Net income avi to common (ttm)-97.99M
Diluted EPS (ttm)-0.83
Quarterly earnings growth (yoy)-98.70%

Balance sheet

Total cash (mrq)336.9M
Total cash per share (mrq)2.92
Total debt (mrq)305.73M
Total debt/equity (mrq)19.74%
Current ratio (mrq)2.82
Book value per share (mrq)13.20

Cash flow statement

Operating cash flow (ttm)60.39M
Levered free cash flow (ttm)-102.99M